Compare GMED & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | AFRM |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.3B |
| IPO Year | 2012 | 2020 |
| Metric | GMED | AFRM |
|---|---|---|
| Price | $94.46 | $62.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 25 |
| Target Price | ★ $100.42 | $84.35 |
| AVG Volume (30 Days) | 990.9K | ★ 4.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 422.67 | 108.98 |
| EPS | ★ 3.92 | 0.60 |
| Revenue | $2,938,931,000.00 | ★ $3,224,412,000.00 |
| Revenue This Year | $11.13 | $30.78 |
| Revenue Next Year | $6.28 | $23.95 |
| P/E Ratio | ★ $24.09 | $110.84 |
| Revenue Growth | 16.65 | ★ 38.80 |
| 52 Week Low | $51.79 | $42.10 |
| 52 Week High | $101.40 | $100.00 |
| Indicator | GMED | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 63.91 |
| Support Level | $85.01 | $42.87 |
| Resistance Level | $97.87 | $79.27 |
| Average True Range (ATR) | 2.77 | 3.13 |
| MACD | 0.41 | 1.72 |
| Stochastic Oscillator | 71.43 | 72.19 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.